These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7114648)

  • 1. Nadolol and papilledema.
    Kaul S; Wong M; Singh BN; Hepler RS
    Ann Intern Med; 1982 Sep; 97(3):454. PubMed ID: 7114648
    [No Abstract]   [Full Text] [Related]  

  • 2. Anxiety and depression in patient on nadolol.
    Russell JW; Schuckit NA
    Lancet; 1982 Dec; 2(8310):1286-7. PubMed ID: 6128589
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.
    Merkel C; Sacerdoti D; Finucci GF; Zuin R; Bazzerla G; Bolognesi M; Gatta A
    Br J Clin Pharmacol; 1986 Jun; 21(6):713-9. PubMed ID: 3741719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices].
    Bertel O; Conen D; Renggli I
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374
    [No Abstract]   [Full Text] [Related]  

  • 5. Advantages and benefits of once-daily nadolol treatment in hypertension.
    González D
    J Int Med Res; 1982; 10(5):351-6. PubMed ID: 6754507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 7. Isometric exercise before and after nadolol treatment in uncomplicated essential hypertension.
    Corea L; Bentivoglio M; Provvidenza M
    Int J Clin Pharmacol Res; 1984; 4(1):35-40. PubMed ID: 6469432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 9. Bilateral optic disc oedema associated with latanoprost.
    Aslanides IM
    Br J Ophthalmol; 2000 Jun; 84(6):673. PubMed ID: 10837399
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nadolol + bendroflumethiazide in a fixed combination and in sequential administration. Experimental research on antihypertensive efficacy and tolerability].
    Del Re ML; Ricci A; Abate G
    Clin Ter; 1986 Mar; 116(5):385-90. PubMed ID: 2871962
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide].
    Gragnoli G; Righi GA; Turchetti V; Mondillo S; Kristodhullu A
    Minerva Med; 1984 Nov; 75(43):2609-15. PubMed ID: 6392936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Our experience on the clinical use of nadolol].
    Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
    Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
    Lo GH; Chen WC; Wang HM; Yu HC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1681-7. PubMed ID: 22849337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute organic brain syndrome from nadolol therapy.
    Wilbur R; Kulik FA; Brecht TC
    Arch Intern Med; 1981 Nov; 141(12):1723-4. PubMed ID: 6118108
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of nadolol and chlorthalidone in hypertensive subjects resistant to therapy with only captopril].
    De Cesaris R; Ranieri G; Chiarappa R; Balestrazzi M; Antoncecchi E
    Clin Ter; 1986 Mar; 116(6):465-71. PubMed ID: 3522061
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
    Cervera J; Torres-Zamora M; Gutiérrez-Carreño R; Fierro M; Schaeffer L; Landa L
    Arch Invest Med (Mex); 1983; 14(4):331-41. PubMed ID: 6678555
    [No Abstract]   [Full Text] [Related]  

  • 17. Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol.
    Shelley ED; Shelley WB
    Cutis; 1985 Feb; 35(2):148-9. PubMed ID: 3979099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
    [No Abstract]   [Full Text] [Related]  

  • 19. Redistribution of cardiac output to the kidneys during oral nadolol administration.
    Textor SC; Fouad FM; Bravo EL; Tarazi RC; Vidt DG; Gifford RW
    N Engl J Med; 1982 Sep; 307(10):601-5. PubMed ID: 7110207
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged bradycardia after neostigmine administration in a patient taking nadolol.
    Seidl DC; Martin DE
    Anesth Analg; 1984 Mar; 63(3):365-7. PubMed ID: 6703355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.